
2015/01/21 22:55 | |
|主訴(Chief Complaint)                                            |
|Informant:patient himself, his wife, and medical records         |
|Intermittant dyspnea with exertional dyspnea since 1 week ago    |
|病史(Brief History)                                              |
|This 48-year-old gentleman has the underlying conditions of 1.   |
|Hepatocellular carcinoma with portal vein thrombosis, cT3N0M0,   |
|Okuda II, Barcelona Clinic Liver Cancer C, status post oral      |
|Sorafenib/UFUR, disease in progression, status post hepatic      |
|arterial infusion chemotherapy with Cisplatin+FL protocol (46,   |
|since 2008/04/24, last course on 2014/12/30). 2. Cirrhosis, Child|
|A/B (PT not tested) with gastric and esophageal varices 3.       |
|Chronic hepatitis B, under Baraclude. 4. Diabetes mellitus, type |
|II. 5. Hypertension The initial presentation was mild RUQ        |
|discomfort since from October 2007. Abdominal sonography at a    |
|local clinic revealed a suspicious 2cm lesion in the liver. He   |
|was referred to NTUH where abdomen MRI revealed liver cirrhosis  |
|and several hypervascular tumors over the right hepatic lobe,    |
|along with several tiny nodules over left hepatic lobe on Oct.   |
|25, 2007. Abdomen echo on Nov. 21, 2007 showed infiltrative      |
|hepatocellular carcinoma with portal vein thrombosis. Liver      |
|biopsy revealed the pathology of hepatocellular carcinoma, and   |
|active HBV related cirrhosis. Hepatocellular carcinoma, T3N0M0,  |
|Okuda II, BCLC C, with Child-Pugh A grade liver cirrhosis was    |
|diagnosed. He received Sorafenib/UFUR initially, with the side   |
|effects of Grade I hand-foot syndrome and diarrhea from Feb. 12, |
|2008 to Apr 2008. Follow-up MRI revealed increasing liver tumors |
|and elevating serum AFP (911.3ng/dl) on Apr. 07, 2008. Systemic  |
|chemotherapy was discontinued, and hepatic arterial infusion     |
|chemotherapy (HAIC) with Cisplatin + FL was initiated. He had    |
|underwent a total of 46 cycles since 2008/04/24 to 2014/12/30.   |
|Hypersensitivity to Cisplatin occurred at the 27th course of HAIC|
|on Jun. 12, 2010, but did not recur in following episodes after  |
|the transfusion of Cisplatin was prolonged to 6hrs. The latest   |
|MRI was obtained on 2014/11/25 revealed that the largest lesion  |
|around 13.1cm with infiltrative pattern at right posterior liver |
|has increased in size, along with tumor thrombosis of right PV.  |
|Progressing disease was the impression. An episode of massive    |
|tarry stool occurred in the night on 2014/11/25, and PES on      |
|2014/11/26 revealed GV bleeding and EV, s/p histacryl injection. |
|Samtosan (Somatostatin ) was administered due to high risk of    |
|rebleeding. During the last 2 HAIC courses, obstruction of the   |
|HAIC catheter were noted with no response to urokinase lock; the |
|catheter was deemed to be patent and flushed by radiologist      |
|through angiographic procedures in both times. The most recent   |
|(46th) course of HAIC with P-FL was administered on 2014/12/30.  |
|Starting from around 2015/1/10, the patient started to experience|
|exertional dyspnea, orthopnea, dry cough during sleep, and       |
|decreased appetite. There was no dysuria, oligouria, diarrhea,   |
|constipation, or fever. He stated that he used to be able to     |
|complete a cycle on the hallway in 10 mins, but now it takes more|
|than 30 to complete one. He also could not climb the stairs as he|
|used to (he could only climb 3 levels of stairs before feeling   |
|dyspnic now.) He took the Inderal prescribed during the last     |
|admission for this condition, but there was no significant       |
|improvement. Due to the condition, he visited a local clinic     |
|which he used to go and had a checkup. Lab exams revealed        |
|elevated AFP (2015/01/17 94110 ng/ml), elevated AST and ALT, and |
|acute kidney injury (Cre 2.83) was noted. He was admitted to our |
|ward for further evaluation. [Past medical history] 1. Systemic  |
|diseases: CAD(-); HTN(+); DM(+); HBV(+); 2. Diet or drugs        |
|allergy: Cisplatin →skin rash, itching 3. Surgery history: Nil   |
|Admissions: Underwent HAIC for 46 times at NTUH since 2008/04/24 |
|4. Current medication: NTUH: Entecavir (Baraclude 0.5 mg/tab) 1  |
|tab QDAC2HR PO Propranolol HCl (Inderal 10 mg/tab) 0.5 tab BID PO|
|Other: 自備藥【Glibudon 500mg】 1 tab PO TIDAC (held due to acute|
|kidney injury) 自備藥【amaryl 2.0mg】 1 tab PO QDAC (decreased to|
|0.5tab QDAC due to acute kidney injury) 自備藥【Glucobay 50mg】 1|
|tab PO TIDAC (decreased to 0.5tab TIDAC due to acute kidney      |
|injury) 自備藥【Januvia 100mg】 1 tab PO QDAC (decreased to      |
|0.5tab QDAC due to acute kidney injury) 自備藥【Valsartan 80mg】 |
|1 tab PO QD (held due to acute kidney injury) 中草藥:nil         |
|保健食品: regular usage of 牛樟芝 5. Blood type: A [Personal and |
|family history] 1. Occupation: 漁會/漁船老板, did not went out to|
|the seas since 2 months ago 2. Financial status: abundant 3.     |
|Traveling history: denied recent traveling, but climbed the hills|
|around his home regularly 4. Habits or addictions: Nil 5. Marital|
|status: married 6. Alcohol(+):drunk(每天醉) for 25 years, quit   |
|for 8 years; Betel nut chewing(+):10-30# qd for 20 years, quit 8 |
|years; Smoking(+):3-4PPD for 25+ years, quit for 8 years; 7.     |
|Family history: father: Liver cancer; mother: HBV carrier        |
|社會心理相關評估(Psychosocial Assessment)                        |
|Social Economic and Personal History 教育程度:國中 職業:無       |
|宗教信仰:道教 婚姻狀態:已婚 使用語言:國語 台語 口述血型:A，RH:不 |
|清楚，輸血反應:有,腹部紅疹 抽煙:沒有，已戒煙:8年 喝酒:沒有，已戒 |
|酒:8年 檳榔:沒有，已戒檳榔:8年 物質濫用: Psychological History   |
|and Evaluation 意識狀態:警醒 認知功能:正常 精神情緒狀態:異常 焦慮|
|安全問題:有 fall down 睡眠形態:異常 早醒 失眠 使用藥物           |
|Nutritional Screen 攝食情形:佳，攝食75% 排便狀態:正常 BMI:33.15  |
|Fall Risk Assessment 總分:3 (>=3分進行不倒翁計畫，請開預防跌倒醫 |
|囑)                                                              |
|系統性回顧(Review of System)                                     |
|1.Systemic: weight loss(-), easy-fatigability(+), night sweats(-)|
|2.Skin: petechiae(-), purpurae(-), skin rash(-), itching(-),     |
|3.HEENT: headache(-),dizziness(-), blurred vision(-),            |
|strabismus(-), ocular pain(-), otalgia(-), otorrhea(-), hearing  |
|impairment(-), tinnitus(-), vertigo(-), nasal stuffiness(-),     |
|nasal discharge(-), epistaxis(-), gum bleeding(-), sore          |
|throat(-),oral ulcer(-) 4.Cardiovascular: exertional chest       |
|tightness(-), nocturnal dyspnea(+), orthopnea(+), syncope(-),    |
|palpitation(-), intermittent claudication(-) 5.Respiratory:      |
|dyspnea(-), cough(+, night time), chest pain(-), hemoptysis(-),  |
|productive cough (-), pleuritic chest pain(-) 6.Gastrointestinal:|
|anorexia(-), nausea(-), vomiting(-), dysphagia(-), heartburn(-), |
|acid regurgitation(-), abdominal fullness(+), hunger pain(-)     |
|midnight pain(-), constipation(-), diarrhea(-), melena(-), change|
|of bowel habit(-), small caliber of stool(-), tenesmus(-),       |
|flatulence(-) 7.Urogenital: flank pain(-), hematuria(-), urinary |
|frequency(-), urgency(-), dysuria (-), hesitancy(-), small stream|
|of urine(-), impotence(-), nocturia(-), polyuria(-), oliguria (-)|
|8.Musculoskeletal: bone pain(-), arthralgia(-), myalgia(-),      |
|weakness(-) back pain(-) 9.Metabolic: heat intolerance(-), cold  |
|intolerance(-), thirsty(-) 10.Nervous: numbness (-),             |
|paresis/plegia (-)                                               |
|身體檢查(Physical Examination)                                   |
|BH:162 cm BW:87 kg T:36.5 P:89 R:20 BP:132/72 mmHg Pain:0        |
|Neurological Examination: . Consciousness: clear and oriented .  |
|Muscle power: symmetric . Gait: stable General appearance: fair, |
|ECOG: 1, Karnofsky performance score: 90 % Head-Eye-ENT          |
|Conjunctiva: pink; Sclera: anicteric; Pupil: isocoric(3mm/3mm);  |
|reflex (+/+) Neck Jugular vein engorgement(-); Lymphadenopathy   |
|(-); Thyroid goiter(-) Chest Thoracic cage contour: symmetric    |
|Auscultation: Crackles(-) wheezes(-) rhonchi(-) stridor(-) Heart |
|Heart beat: regular Adventitious sounds (-); Murmurs(-) Abdomen  |
|Ovoid & soft Superficial vein engorgement(-) Protruded           |
|umbilicus(-) Bowel sound: normo-active Tenderness(-) Shifting    |
|dullness (-) Liver and spleen: impalpable Extremities: Freely    |
|movable, pitting edema (-), pulsations: symmetric Skin Abnormal  |
|pigmentation(-) Petechiae(-) Purpura(-) Ecchymoses(-)            |
|Telangiectasia(-) Rash(+, papules around 3mm with erythema and   |
|curst located diffusely on the trunk and limbs, with pruritis)   |
|Plaque(-) Wound(-) Ulceration(-) Crust(-) Inguinal               |
|lymphadenopathy(-); Axillary lymphadenopathy (-)                 |
|檢驗紀錄(Laboratory Report)                                      |
|*********檢驗室:RL*********** 群組:Biochemistry BUN CRE Na K     |
|T-BIL time/item (mg/dL) (mg/dL) (mmol/L) (mmol/L) (mg/dL) 1040121|
|[1023] 24.4 1.1 130 4.8 1.43 Ca time/item (mmol/L) 1040121 [1023]|
|2.22 群組:CBC+PLT WBC RBC HB HCT MCV time/item (K/μL) (M/μL)     |
|(g/dL) (%) (fL) 1040121 [1023] 4.15 3.47 10.4 31.4 90.5 MCH MCHC |
|PLT RDW-CV PS time/item (pg) (g/dL) (K/μL) (%) () 1040121 [1023] |
|30.0 33.1 173 18.1 - 群組:WBC Classification Blast Promyl. Myelo.|
|Meta Band time/item (%) (%) (%) (%) (%) 1040121 [1023] 0.0 0.0   |
|0.0 0.0 0.0 Seg Eos. Baso. Mono. Lym. time/item (%) (%) (%) (%)  |
|(%) 1040121 [1023] 50.0 4.8 0.2 14.2 30.8 Aty.Lym. PlasmaCell    |
|Normobl. PS time/item (%) (%) () () 1040121 [1023] 0.0 0.0 0 -   |
|群組:General BioChemistry ALB ALT ALP LDH time/item (g/dL) (U/L) |
|(U/L) (U/L) 1040121 [1023] 3.1 37 93 264                         |
|*********檢驗室:OP*********** 群組:SEDIMENT RBC (S) WBC (S) Epith|
|(S) Cast (S) Crystal (S) time/item (/HPF) (/HPF) (/HPF) (/LPF)   |
|(*) 1040121 [1741] 0-2 0-2 0-2 - - Bacteria Mucus(S) Others (S)  |
|time/item (*) (*) (*) 1040121 [1741] - - - 群組:MULTISTIX Sp.    |
|Gr.(C) pH Protein(C) Glu.(C) Ketone body (U) time/item (*) (*)   |
|(mg/dL) (mg/dL) (*) 1040121 [1741] 1.012 7.0 - - - O.B.(C)       |
|Urobil.(C) Bil.(C) Nitrite(C) WBC esterase (U) time/item (mg/dL) |
|(mg/dL) (mg/dL) (*) (*) 1040121 [1741] - 2.0 - - - Color         |
|Turbidity time/item (*) (*) 1040121 [1741] Yellow -              |
|*********檢驗室:PO*********** 群組: Sugar(One to uch) time/item  |
|(*) 1040121 [1723] 113                                           |
|檢查紀錄(Examination Report)                                     |
|nil                                                              |
|影像報告(Imaging Report)                                         |
|nil                                                              |
|病理報告(Pathology Report)                                       |
|096/11/28 S0736651 Liver,needle biopsy,hepatocellular carcinoma  |
|grade II,cirrhosis active,HBV related,                           |
|臆斷(Tentative Diagnosis)                                        |
|1. Hepatocellular carcinoma with portal vein thrombosis, cT3N0M0,|
|Okuda II, Barcelona Clinic Liver Cancer C, status post oral      |
|Sorafenib/UFUR, disease in progression, status post hepatic      |
|arterial infusion chemotherapy with Cisplatin+FL protocol (46,   |
|since 2008/04/24, last course on 2014/12/30). 2. Cirrhosis, Child|
|A/B (PT not tested) with gastric and esophageal varices 3.       |
|Chronic hepatitis B, under Baraclude. 4. Diabetes mellitus, type |
|II. 5. Hypertension                                              |
|醫療需求與治療計畫(Medical Needs and Care Plan)                  |
|1. Acute kidney injury A: Elevated creatinine level noted at LMD |
|(Cre 2.83) on 2015/01/17, but findings at NTUH was only 1.1,     |
|similiar to prior results (0.8) Denied usage of new herbal       |
|medicine or prescription drugs No sign of fluid overload. No     |
|dysuria. P: monitor U/O. Close follow-up. Consider renal         |
|sonography follow-up. 2. Hepatocellular carcinoma A: Most recent |
|image study (MRI) in November 2014 revealed PD, with elevated AFP|
|noted in the past month. No ascites noted. P: Arrange CT scan for|
|brain+chest+abdomen+pelvis Arrange TACE. 3. Newly developed      |
|exertional dyspnea A: Condition developed in the past week, with |
|orthopnea and night cough also noted. No pitting edema. CXR:     |
|cardiomegaly, with suspected pattern of cephalization P: EKG.    |
|Consider cardiac sonography. Treatment Goal: Complete workup of  |
|the conditoons ========【ONCOLOGY SUMMARY】======== 【Initial    |
|presentation】 2007/10 mild RUQ discomfort not related to meal.  |
|【Definite diagnosis and Disease extend】 2007/10/25 MRI: liver  |
|cirrhosis, several hypervascular tumors over right hepatic lobe  |
|2007/11/21 Abdomen echo: infiltrative HCC portal vein thrombosis |
|and biopsy 2007/11/22: Pathology: hepatocellular carcinoma, and  |
|active HBV related★ Diagnosis: Hepatocellular carcinoma, staging |
|T3N0M0, Okuda II, liver cirrhosis child-P A. 【Treatment plan,   |
|effect and side effect】2008/02/12~2008/04/07 Sorafenib/UFUR     |
|trial＊Side effect: grade I of head-foot syndrome, diarrhea      |
|⊙Effect: 2008/04/07 MRI: disease progression; AFP elevated to    |
|911.3ng/dl →PD 2008/04/24~2008/08/07 IA Cisplatin+FL(1~6)        |
|⊙Effect: 2008/08/22 MRI: stationary 2008/09/02~2008/10/30 IA     |
|Cisplatin+FL(7~9) ⊙Effect: 2008/11/18 MRI: liver mass decreased  |
|2008/11/18~2009/01/15 IA Cisplatin+FL(10~12) ⊙Effect: 2009/02/09:|
|MRI: stationary 2009/02/09~2009/04/22 IA Cisplatin+FL(13~16)     |
|⊙Effect: 2009/05/18: MRI: PR 2009/05/18~2009/08/15 IA            |
|Cisplatin+FL(17~20) ⊙Effect: 2009/09/08 MRI: PR                  |
|2009/09/09~2009/12/05 IA Cisplatin+FL(21~24) ＊Side effect: hot  |
|flush, mild dyspnea, shortness of breath, bilateral hands        |
|rednesswith itch and injected throat when Cisplatin infusion of  |
|the 20th to 23rd cycle of chemotherapy ⊙Effect: 2010/01/05 MRI:  |
|PR 2010/01/05 IA Cisplatin+FL(25) ⊙Effect: 2010/06/12 MRI:       |
|increased liver tumors, PD 2010/06/11~2010/08/27 IA Cisplatin+FL |
|(26~29) ＊Side effect:: severe cough, general hot sensation, and |
|bilateral palmer redness developed after Cisplatin infusion      |
|30minutes on Jun. 12, 2010; hypersensitivity of cisplatin;       |
|prolonged the cisplatin infusion time to 6 hours from the 28th   |
|cycle 2010/09/30~2010/12/23 IA Cisplatin+FL(30~32) ⊙Effect:      |
|2011/01/27 MRI: stationary disease, 2010/12/23 AFP 7.26 ng/ml    |
|2011/01/27~2011/06/18 IA Cisplatin+FL(33~36) ⊙Effect: 2011/06/16 |
|MRI: An infiltrative HCC at right lobe, size smaller.PR,         |
|2011/06/16 AFP 8.34 ng/ml 2011/08/18~2011/10/15 IA               |
|Cisplatin+FL(37~38) (Q2M) ⊙Effect: 2011/12/12 Abdomen MRI: 1. A  |
|stationary infiltrative hepatic tumor, right lobe of liver. 2.   |
|Multiple hepatic nodules, R/O cirrhotic nodules. 3. Hepatic      |
|nodule, lateral segment, R/O HCC. D/D cirrhotic nodule. 4.       |
|Hepatic nodule, S7, R/O arterioportal shunt or small             |
|HCC.-->Stable disease 2011/12/12 IA Cisplatin+FL(39) (Q2M).      |
|⊙Effect: 2012/03/26 MRI: PR 2012/03/27 IA Cisplatin+FL(40)       |
|2012/06/29 IA Cisplatin+FL(41) ⊙Effect:2012/10/23 MRI: Two       |
|definite recurrent HCCs at S#2(1.8cm) and at S#7(2cm) of liver;  |
|Three nodules at high S#8(0.6cm), at anterior S#2(1.5cm), and at |
|S#1(1.7cm) of liver-->Stable ⊙Effect:2013/1/21 MRI: Two small    |
|hepatic nodules, S2 and S7-->Stable disease! ⊙Effect:2013/4/30   |
|MRI: multiple (at least 6) nodules in both hepatic lobes, showed |
|moderate enhancement in HA phase, iso- to mild hypointense in PV |
|and delayed phase, the largest one (3.6cm) at S#7 2013/06/14     |
|IA-HAIC Cisplatin+FL(42) ⊙Effect:2013/08/29 MRI: S2(2.1cm) and   |
|S7(2.9cm) of the liver(size↓)-->PR 2013/08/29 IA-HAIC            |
|Cisplatin+FL(43) ⊙Effect:2014/07/04 MRI: at least six viable HCCs|
|in both hepatic lobes, the largest one(4.5cm) at right superior  |
|liver. tumor thrombosis of right PV.-->PD 2014/07/29 IA-HAIC     |
|Cisplatin+FL(44) ⊙Effect:2014/11/25 MRI: progressing disease of  |
|one largest lesion around 13.1cm with infiltrative pattern at    |
|right posterior liver, size enlarged.-->PD 2014/11/25 HAIC       |
|catheter angiography: patent 2014/11/26 massive tarry stool-->   |
|PES: GV bleeding and EV s/p histacryl injection. 2014/12/08 HAIC |
|catheter angiography: patent 2014/12/08 IA-HAIC Cisplatin+FL(45) |
|⊙Effect:2014/12/2x AFP ~40000 ng/ml (LMD) 2014/12/30 HAIC        |
|catheter angiography: patent 2014/12/30 IA-HAIC Cisplatin+FL(46) |
|--> no discomfort ⊙Effect:2014/12/31 AFP 19104.83 ng/ml (NTUH)   |
|⊙Effect:2015/01/17 AFP 94110 ng/ml (LMD)                         |
|出院規劃(Discharge Planning)                                     |
|管路留置狀況:有 靜脈管路留置(含Hickman / Port-A)：無             |
|雙腔導管留置：無 鼻胃管留置： 氣管管路留置：無 胃造廔口：無 尿管 |
|留置：無 膀胱造廔：無 傷口引流管：無 其他導管：right feneral HAIC|
|日常生活功能分數：100 預期出院後居住場所：與家人同住             |
|預期出院後主要照顧者：自己 配偶 出院規劃收案篩檢：一般病患       |
|主治醫師評論(VS Comments)                                        |
|I agree with the assessment made by the resident.                |
|醫師姓名                                                         |
|林宗哲 主治醫師                                                  |

